Clinical Trials in Portland

Showing 6421-6440 of 10,048 trials

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis

NCT02398292

The purpose of this study is to determine the feasibility (≥ 50% completion rate) of a 6-week nutrition, movement, and mindfulness program for youth with recent diagnosis of psychosis.

SchizophreniaPsychotic Disorders

Oregon Health and Science University33 participantsStarted Feb 2015

Portland, Oregon, United States

UNKNOWNPhase 4< 1 mile

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

NCT03965208

This study will evaluate heparin as compared to bivalirudin for systemic anticoagulation in adult patients that require extracorporeal membrane oxygenation (ECMO). Half of the participants will receive heparin and half will receive bivalirudin.

Extracorporeal Membrane Oxygenation ComplicationAnticoagulants

Legacy Health System34 participantsStarted May 2019

Portland, Oregon, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

NCT02240030

This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing motor response fluctuations (OFF phenomena) as an outpatient (i.e., at home) and in the clinic. Patients who successfully complete this study will be eligible to enroll into a 12 month treatment extension (CVT-301-004E) study.

Idiopathic Parkinson's Disease

Acorda Therapeutics351 participantsStarted Nov 2014

Scottsdale, Arizona, United States • Fresno, California, United States • Fullerton, California, United States +71 more locations

A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Find Trials by Condition in Portland

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

Safety and Efficacy of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients

Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

The Chimerix CMX001 Registry

National Observational Study of Clinical Practices in Deceased Organ Donation

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Randomized Safety Study of CVT-301 Compared to an Observational Control Group